Investor Relations

Corporate Profile

Procaps Group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have direct presence in 13 countries in Latin America and we have more than 5,000 collaborators working under a sustainable model.

Develop, manufacture, and market over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potential clinical solutions.

Stock Quote

Price

Change

High

Minimum 15 minutes delayed. Source: LSEG



Investor Contact Information

Company

Procaps Group
9 Rue De Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Procaps Group Company Contact
Melissa Angelini
Investor Relations Director
ir@procapsgroup.com
mangelini@procapsgroup.com

Search Investor Relations